Your browser doesn't support javascript.
loading
What risk of death would people take to be cured of HIV and why? A survey of people living with HIV.
Murray, Benjamin R; Kratka, Allison; Scherr, Karen A; Eyal, Nir; Blumenthal-Barby, Jennifer; Freedberg, Kenneth A; Kuritzkes, Daniel R; Hammitt, James K; Edifor, Regina; Katz, Madelaine N; Pollak, Kathryn I; Zikmund-Fisher, Brian J; Halpern, Scott D; Barks, Mary C; Ubel, Peter A.
Afiliação
  • Murray BR; Duke University School of Medicine, Durham, NC, USA.
  • Kratka A; Duke University School of Medicine, Durham, NC, USA.
  • Scherr KA; Duke University School of Medicine, Durham, NC, USA.
  • Eyal N; Duke University Fuqua School of Business, Durham, NC, USA.
  • Blumenthal-Barby J; Harvard TH Chan School of Public Health, Boston, MA, USA.
  • Freedberg KA; Baylor College of Medicine, Center for Medical Ethics and Health Policy, Houston, TX, USA.
  • Kuritzkes DR; Harvard TH Chan School of Public Health, Boston, MA, USA.
  • Hammitt JK; Medical Practice Evaluation Center, Divisions of General Internal Medicine and Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Edifor R; Harvard Medical School, Boston, MA, USA.
  • Katz MN; Harvard Medical School, Boston, MA, USA.
  • Pollak KI; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Zikmund-Fisher BJ; Harvard TH Chan School of Public Health, Boston, MA, USA.
  • Halpern SD; Toulouse School of Economics, University of Toulouse Capitole, Toulouse, France.
  • Barks MC; University of Massachusetts Medical School, Worcester, MA, USA.
  • Ubel PA; Duke University Fuqua School of Business, Durham, NC, USA.
J Virus Erad ; 5(2): 109-115, 2019 Apr 01.
Article em En | MEDLINE | ID: mdl-31191914
ABSTRACT
People living with HIV (PLWHIV) can reasonably expect near-normal longevity, yet many express a willingness to assume significant risks to be cured. We surveyed 200 PLWHIV who were stable on antiretroviral therapy (ART) to quantify associations between the benefits they anticipate from a cure and their risk tolerance for curative treatments. Sixty-five per cent expected their health to improve if cured of HIV, 41% predicted the virus would stop responding to medications over the next 20 years and 54% predicted experiencing serious medication side effects in the next 20 years. Respondents' willingness to risk death for a cure varied widely (median 10%, 75th percentile 50%). In multivariate analyses, willingness to risk death was associated with expected long-term side effects of ART, greater financial resources and being employed (all P < 0.05) but was not associated with perceptions of how their health would improve if cured.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article